Cargando…

Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy

Atrial fibrillation (AF) and chronic kidney disease (CKD) are strictly related; several independent risk factors of AF are often frequent in CKD patients. AF prevalence is very common among these patients, ranging between 15% and 20% in advanced stages of CKD. Moreover, the results of several studie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magnocavallo, Michele, Bellasi, Antonio, Mariani, Marco Valerio, Fusaro, Maria, Ravera, Maura, Paoletti, Ernesto, Di Iorio, Biagio, Barbera, Vincenzo, Della Rocca, Domenico Giovanni, Palumbo, Roberto, Severino, Paolo, Lavalle, Carlo, Di Lullo, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796391/ https://www.ncbi.nlm.nih.gov/pubmed/33379379 http://dx.doi.org/10.3390/jcm10010083

Ejemplares similares

Predictive Value of Measures of Vascular Calcification Burden and Progression for Risk of Death in Incident to Dialysis Patients
por: Bellasi, Antonio, et al.
Publicado: (2021)

A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy
por: Chimenti, Cristina, et al.
Publicado: (2021)

Vascular Calcification Progression Modulates the Risk Associated with Vascular Calcification Burden in Incident to Dialysis Patients
por: Bellasi, Antonio, et al.
Publicado: (2021)

Five Years of Direct Oral Anticoagulants Use in Italy: Adverse Drug Reactions from the Italian National Pharmacovigilance Network
por: Lavalle, Carlo, et al.
Publicado: (2022)

Chronic Kidney Disease: The Silent Epidemy
por: Bellasi, Antonio, et al.
Publicado: (2019)

Finerenone: Questions and Answers—The Four Fundamental Arguments on the New-Born Promising Non-Steroidal Mineralocorticoid Receptor Antagonist
por: Di Lullo, Luca, et al.
Publicado: (2023)

Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis
por: Mariani, Marco Valerio, et al.
Publicado: (2020)

Very Low Protein Diet for Patients with Chronic Kidney Disease: Recent Insights
por: Di Micco, Lucia, et al.
Publicado: (2019)

New Challenges in Heart Failure with Reduced Ejection Fraction: Managing Worsening Events
por: Lavalle, Carlo, et al.
Publicado: (2023)

Kidney Disease in HIV Infection
por: Alfano, Gaetano, et al.
Publicado: (2019)

Pathophysiology of the cardio-renal syndromes types 1–5: An uptodate
por: Di Lullo, L., et al.
Publicado: (2017)

Fractional Excretion of Phosphate (FeP) Is Associated with End-Stage Renal Disease Patients with CKD 3b and 5
por: Bellasi, Antonio, et al.
Publicado: (2019)

Impact of COVID-19 Pandemic on Cardiac Electronic Device Management and Role of Remote Monitoring
por: Magnocavallo, Michele, et al.
Publicado: (2022)

Catheter ablation for papillary muscle arrhythmias: A systematic review
por: Mariani, Marco Valerio, et al.
Publicado: (2022)

QT interval in CKD and haemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2013)

Phosphate Metabolism Modulation in Chronic Kidney Disease: When, How and to What Extent?
por: Bellasi, Antonio, et al.
Publicado: (2014)

Correction of metabolic acidosis improves insulin resistance in chronic kidney disease
por: Bellasi, Antonio, et al.
Publicado: (2016)

Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Lesson from the RIETE Registry
por: Di Micco, Pierpaolo, et al.
Publicado: (2019)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
por: Lecumberri, Ramón, et al.
Publicado: (2021)

Prevalence and Clinical Implications of COVID-19 Myocarditis
por: Chimenti, Cristina, et al.
Publicado: (2022)

Correction to: Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study
por: Di Iorio, Biagio R., et al.
Publicado: (2020)

Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study
por: Di Iorio, Biagio R., et al.
Publicado: (2019)

Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
por: Wallvik, Niklas, et al.
Publicado: (2020)

Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
por: de Winter, Maria A, et al.
Publicado: (2023)

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
por: Poénou, Géraldine, et al.
Publicado: (2023)

Recurrent thromboembolism, bleeding, and mortality in Asian patients with venous thromboembolism receiving different oral anticoagulants: A nationwide analysis
por: Lee, Mei-Chuan, et al.
Publicado: (2022)

Post-polypectomy bleeding and thromboembolism risks associated with warfarin vs direct oral anticoagulants
por: Yanagisawa, Naohiro, et al.
Publicado: (2018)

Thromboembolic and bleeding risk of periprocedural bridging anticoagulation: A systematic review and meta‐analysis
por: Kuo, Hsien‐Cheng, et al.
Publicado: (2020)

Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding
por: MacLehose, Richard F., et al.
Publicado: (2021)

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
por: Wells, Philip S., et al.
Publicado: (2022)

Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review
por: Ballestri, Stefano, et al.
Publicado: (2022)

Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism
por: López-Núñez, Juan J., et al.
Publicado: (2019)

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
por: Cozzolino, Mario, et al.
Publicado: (2017)

Bleeding and thromboembolic risk in patients under anticoagulant therapy receiving oral surgery: a systematic review
por: Moldovan, Madalina A., et al.
Publicado: (2023)

Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS‐BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment
por: Brown, Joshua D., et al.
Publicado: (2018)

Real-life data of direct anticoagulant use, bleeding risk and venous thromboembolism recurrence in chronic thromboembolic pulmonary hypertension patients: an observational retrospective study
por: Sena, Sert, et al.
Publicado: (2020)

Treatment of venous thromboembolism – effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management
por: Hass, Bastian, et al.
Publicado: (2012)

Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry
por: Königsbrügge, Oliver, et al.
Publicado: (2016)

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin
por: Boonyawat, Kochawan, et al.
Publicado: (2021)

Claims‐Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism
por: Alonso, Alvaro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uhkltgifllmerp2su8m76fjhs4